Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New herpes test may warn of Kaposi's sarcoma:

This article was originally published in Clinica

Executive Summary

US firm American Biogenetic Sciences (ABS) and the University of Maryland plan to develop a simple, reliable and inexpensive blood test to detect a newly discovered herpes virus. As well as detecting the sexually-transmitted Human Herpes Virus Type 8, the test might also help predict whether a patient will develop Kaposi's sarcoma (KS), a fatal form of cancer which has recently been shown to be strongly associated with the virus (see Nature, August 6). Copiague, New York-based ABS said that treating KS earlier could lead to better outcomes for patients.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT083319

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel